V3640

Valpromide

≥97% (NMR)

• 동의어(들): 2-Propylvaleramide, 2-propyl-pentanamide, Depamid, Depamide, Di-n-propylacetamide, Dipropylacetamide
• 실험식(Hill 표기법): C₈H₁₇NO
• CAS Number: 2430-27-5
• Molecular Weight: 143.23
• MDL number: MFCD00051534
• UNSPSC 코드: 12352200
• PubChem Substance ID: 329829044
• NACRES: NA.77

속성

• Quality Level: 100
• 분석: ≥97% (NMR)
• 양식: powder
• 색상: white to off-white
• solubility: DMSO: >10 mg/mL
• 주관자: Sanofi Aventis
• 저장 온도: room temp
• SMILES string: CCCC(CCC)C(N)=O
• InChI: 1S/C8H17NO/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H2,9,10)
• InChI key: OMOMUFTZPTXCHP-UHFFFAOYSA-N

설명

애플리케이션

Valpromide has been used to pretreat NIH/3T3 cells to test its effect on cytomegalovirus (CMV) viral replication. It has also been used to test its antiviral functionality in herpes simplex virus type 1 (HSV-1) infected human oligodendroglioma (HOG) cells. It may be used to test its effect on apoptosis induction in astrocytes.

생화학적/생리학적 작용

Valpromide (VPD) is a derivative of valproic acid (VPA) and is used as an antiepileptic drug.

Valpromide (VPD) is a derivative of valproic acid (VPA) and is used as an antiepileptic drug. It is hydrolyzed quickly to VPA in vivo, but has intrinsic anticonvulsant activity.

Valpromide possesses antipsychotic property. It lacks the toxic and teratogenic effects of valproic acid. It also lacks the histone deacetylase (HDAC) inhibitory activity of valproic acid.

특징 및 장점

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

안전성 정보

• 픽토그램: GHS07
• 신호어: Warning
• 유해 및 위험 성명서: H302
• 예방조치 성명서: P264 - P270 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable